June 26, 2017
Nobuo Murakami, vice president, Global Specialty & Value Products Marketing Daiichi Sankyo’s novel oral anticoagulant edoxaban is steadily growing its market share not only in Japan but in Europe and South Korea as well. “We’ve achieved major reforms of our...read more